Adolescent Drug Abuse MDFT Case Study (Part 1 of 2)


 

Adolescent Drug Abuse MDFT Case Study (Part 1 of 2) – This is a presentation of a typical MDFT case. It is Part 1 of 2. To see additional videos, including part two of this case presentation, please go to our YouTube channel (www.youtube.com ), or go directly to the videos using the following links: (1) Multidimensional Family Therapy, An Introduction (Part 1 of 2) www.youtube.com (2) Multidimensional Family Therapy, An Introduction (Part 2 of 2) www.youtube.com (3) Risk and Protective Factors www.youtube.com (4) MDFT – Juvenile Justice www.youtube.com (5) Adolescent Treatment www.youtube.com (6) Adolescent Drug Abuse MDFT Case Study (Part 1 of 2) www.youtube.com (7) Adolescent Drug Abuse MDFT Case Study (Part 2 of 2) www.youtube.com (8) Future of Adolescent Treatment and Research www.youtube.com (9) Dr. Howard Liddle, Multidimensional Family Therapy DVD (APA Video Series) www.youtube.com (10) MDFT (Multidimensional Family Therapy, in Dutch with English subtitles) www.youtube.com (11) MDFT (Multidimensional Family Therapy, Dutch version) www.youtube.com (12) MDFT (Multidimensional Family Therapy, German version) www.youtube.com About Dr. Howard Liddle: Howard A. Liddle, EdD, ABPP (Family Psychology), is Professor, in the Departments of Epidemiology and Public Health and Psychology, and Director, of the Center for Treatment Research on Adolescent Drug Abuse at the University of Miami Miller School of Medicine (www.miami.edu\ctrada).Trained as a psychologist and family therapist, Dr. Liddle directs a long term program of

 

Controlled chaos: Davison family thankful after adopting eighth child

Filed under: drug abuse treatment outcome study

Pamela said Grace was born drug addicted and had a stroke. … They have a son who is an attorney, a daughter who is set to receive her master's degree in nursing at the age of 22, a daughter who served in the military and is studying to treat combat …
Read more on The Flint Journal – MLive.com

 

Actelion submits the registration dossier for macitentan (Opsumit) to the

Filed under: drug abuse treatment outcome study

The United States Food and Drug Administration had already received the registration dossier on October 22 nd 2012. Macitentan, a novel oral dual endothelin receptor antagonist, was studied in the pivotal, long-term, event-driven Phase III outcome …
Read more on Reuters

 

Arizona Pain Specialists Responds to Alarming Media Reports on Prescription

Filed under: drug abuse treatment outcome study

Both the November 11, 2012 L.A. Times article “Legal Drugs, Deadly Outcomes” and CNN's November 18 “Deadly Dose” documentary, addressed the skyrocketing prescription drug epidemic in the United States. Statistics report that every 19 minutes … Lynch …
Read more on Melodika.net (press release)